NCT05047224Completed
Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool
Addressing Disparities in ASD Diagnosis Using a Direct-to-home Telemedicine Tool: Evaluation of Diagnostic Accuracy, Psychometric Properties, and Family Engagement
Source: ClinicalTrials.gov · Last updated 21 Aug 2026
Brief summary (registry, in English)
The investigators propose to evaluate the use of a telemedicine tool, the TELE-ASD-PEDS (TAP), that is designed to assess for autism spectrum disorder (ASD) symptoms in toddlers. The TAP was developed at VUMC by a team of clinical psychologists with expertise in the early identification of ASD. The TAP has been studied in controlled laboratory settings, with high levels of family and clinician satisfaction, as well as excellent agreement with blinded comprehensive ASD evaluation. The TAP has also been used to complete direct-to-home telemedicine assessments during the COVID-19 pandemic. However, the investigators have not yet compared direct-to-home assessments using the TAP with gold standard, in-person ASD assessments. It has also not yet been studied in a diverse sample of families or with providers outside of VUMC. This study will allow the investigators to address those gaps.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 664 (actual)
- First submitted
- 7 Sept 2021
- Start date
- 3 Dec 2021
- Primary completion date
- 10 Mar 2026
- Lead sponsor
- Vanderbilt University Medical Center
- Diseases
- Autism
- NCT number
- NCT05047224
What you commit to
- Study type: Interventional
- Participants enrolled: 664
- From 3 Dec 2021 to the primary completion date, 10 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe sensorimotor impairment that cannot be corrected and would interfere with completion of study activities
- Medical conditions for which tele-evaluation of ASD symptoms is likely to be inappropriate or complex (i.e., rare genetic syndromes, severe epilepsy, fragile health).
Who the study is looking for
- Child between 18 and 42 months of age
- Child and primary caregiver live within a 3-hour driving radius of one of the sites (i.e., VUMC or UC Davis)
- Age 18 years or older
- Parent or legal guardian of participating child
- Has access to technology (e.g., phone, laptop, or tablet with internet connection and audio-visual capabilities) to connect to the tele-assessment platform
- Sufficient facility with English to participate in the procedures and complete study measures.
Age in the registry: 18 months to 42 months · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UC Davis MIND Institute Coordinator of this site? Confirm its status | Sacramento | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.